Tanshinone IIA prevents cardiac remodeling through attenuating NAD (P)H oxidase-derived reactive oxygen species production in hypertensive rats

Pharmazie

Volumn 66, Issue 7, 2011, Pages 517-524

  Wang, Ping ^a,b   Wu, Xiaoqian ^a,c   Bao, Yingxia ^a   Fang, Jian ^a   Zhou, Sigui ^a   Gao, Jie ^a   Pi, Rongbiao ^a   Mou, Yong Gao ^a   Liu, Peiqing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b Shenzhen Institute for Drug Control   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; TANSHINONE IIA; ABIETANE DERIVATIVE; CARDIOTONIC AGENT; ENZYME INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TANSHINONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; BORDERLINE HYPERTENSIVE RAT; CONTROLLED STUDY; ENZYME ACTIVITY; HEART FAILURE; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART PROTECTION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; RENOVASCULAR HYPERTENSION; ANIMAL; CARDIOMEGALY; CORONARY ARTERY BLOOD FLOW; DRUG ANTAGONISM; DRUG EFFECT; ECHOGRAPHY; FIBROSIS; HEART DISEASE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; HEART STROKE VOLUME; HEMODYNAMICS; METABOLISM; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CARDIOMEGALY; CARDIOTONIC AGENTS; CORONARY CIRCULATION; DITERPENES, ABIETANE; ENZYME INHIBITORS; FIBROSIS; HEART DISEASES; HEMODYNAMICS; HYPERTENSION, RENOVASCULAR; MALE; MYOCARDIUM; NADPH OXIDASE; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROKE VOLUME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 80051953046     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2011.0806     Document Type: Article

References (38)

1. Ago T, Kitazono T, Ooboshi H, Iyama T, Han YH, Takada J, Wakisaka M, Ibayashi S, Utsumi H, Iida M (2004) Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 109: 227-233. (Pubitemid 38114144)
2. Albers DS, Beal MF (2002) Mitochondrial dysfunction in progressive supranuclear palsy. Neurochem Int 40: 559-564. (Pubitemid 34159157)
3. Bedard K, Krause KH (2007) The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 87: 245-313. (Pubitemid 46209993)
4. Bendall JK, Cave AC, Heymes C, Gall N, Shah AM (2002) Pivotal role of a gp91 (phox)-containing NADPH oxidase in angiotensin II-induced cardiac hypertrophy in mice. Circulation 105, 293-296. (Pubitemid 34106175)
5. Berk BC, Fujiwara K, Lehoux S (2007) ECM remodeling in hypertensive heart disease. J Clin Invest 117: 568-575. (Pubitemid 46348511)
6. Byrne JA, Grieve DJ, Bendall JK, Li JM, Gove C, Lambeth JD, Cave AC, Shah AM (2003) Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy. Circ Res 93: 802-805.
7. Cifuentes ME, Rey FE, Carretero OA, Pagano PG (2000) Upregulation of p67 (phox) and gp91 (phox) in aortas from angiotensin II-infused mice. Am J Physiol Heart Circ Physiol 279: H2234-2240.
8. Cucoranu I, Clempus R, Dikalova A, Phelan PJ, Ariyan S, Dikalov S, Sorescu D (2005) NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts, Circ Res 97: 900-907. (Pubitemid 41552675)
9. Ertl G, Frantz S (2005) Healing after myocardial infarction, Cardiovasc Res 66: 22-32. (Pubitemid 40360705)
10. Fu J, Huang H, Liu J, Pi R, Chen J, Liu P (2007) Tanshinone IIA protects cardiac myocytes against oxidative stress-triggered damage and apoptosis, Eur J Pharmacol 568: 213-221. (Pubitemid 46976900)
11. Gao J, Yang G, Pi R, Li R, Wang P, Zhang H, Le K, Chen S, Liu P (2008) Tanshinone IIA protects neonatal rat cardiomyocytes from adriamycin-induced apoptosis. Transl Res 151: 79-87.
12. Griendling KK, Sorescu D, Ushio-Fukai M (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501. (Pubitemid 30165039)
13. Hare JM (2001) Oxidative stress and apoptosis in heart failure progression. Circ Res 89: 198-200.
14. Jalil JE, Perez A, Ocaranza MP, Bargetto J, Galaz A, Lavandero S (2005) Increased aortic NADPH oxidase activity in rats with genetically high angiotensin-converting enzyme levels. Hypertension 46: 1362-1367. (Pubitemid 43189736)
15. Johar S, Cave AC, Narayanapanicker A, Grieve DJ, Shah AM (2006) Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase. Faseb J 20: 1546-1548.
16. Jugdutt BI (2003) Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough? Circulation 108: 1395-1403.
17. Khaper N, Kaur K, Li T, Farahmand F, Singal PK (2003) Antioxidant enzyme gene expression in congestive heart failure following myocardial infarction. Mol Cell Biochem 251: 9-15. (Pubitemid 37220703)
18. Lambeth JD (2004) NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 4: 181-189.
19. Lassegue B, Clempus RE (2003) Vascular NAD(P)H oxidases: specific features, expression, and regulation, Am J Physiol Regul Integr Comp Physiol 285: R277-R279.
20. Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y, Grant SL, Lambeth JD, Griendling KK (2001) Novel gp91 (phox) homologues in vascular smooth muscle cells: nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways, Circ Res 88: 888-894. (Pubitemid 32441466)
21. Liao Y, Asakura M, Takashima S, Ogai A, Asano Y, Shintani Y, Minamino T, Asanuma H, Sanada S, Kim J, Kitamura S, Tomoike H, Hori M, Kitakaze M (2004) Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice. Circulation 110: 692-699. (Pubitemid 39056268)
22. Looi YH, Grieve DJ, Siva A, Walker SJ, Anilkumar N, Cave AC, Marber M, Monaghan MJ, Shah AM (2008) Involvement of Nox2 NADPH oxidase in adverse cardiac remodeling after myocardial infarction. Hypertension 51: 319-325. (Pubitemid 351159945)
23. Lu L, Quinn MT, Sun Y (2004) Oxidative stress in the infarcted heart: role of de novo angiotensin II production, Biochem Biophys Res Commun 325: 943-951. (Pubitemid 39487963)
24. Minuz P, Patrignani P, Gaino S, Degan M, Menapace L, Tommasoli R, Seta F, Capone ML, Tacconelli S, Palatresi S, Bencini C, Del Vecchio C, Mansueto G, Arosio E, Santonastaso CL, Lechi A, Morganti A, Patrono C (2002) Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation 106: 2800-2805. (Pubitemid 35396979)
25. Murdoch CE, Zhang M, Cave AC, Shah AM (2006) NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovasc Res 71: 208-215.
26. Nakagami H, Takemoto M, Liao JK (2003) NADPH oxidase-derived superoxide anion mediates angiotensin II-induced cardiac hypertrophy. J Mol Cell Cardiol 35: 851-859. (Pubitemid 36773597)
27. Rugale C, Cordaillat M, Mimran A, Jover B (2005) Prevention and reversal by enalapril of target organ damage in angiotensin II hypertension. J Renin Angiotensin Aldosterone Syst 6, 154-160. (Pubitemid 43263355)
28. Shiomi T, Tsutsui H, Matsusaka H, Murakami K, Hayashidani S, Ikeuchi M, Wen J, Kubota T, Utsumi H, Takeshita A (2004) Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 109: 544-549. (Pubitemid 38168520)
29. Sorescu D,Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP,Valppu L, Quinn MT, Lambeth JD, Vega JD, Taylor WR, Griendling KK (2002) Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105: 1429-1435. (Pubitemid 34263273)
30. Sun ZJ, Zhang ZE (2005) Historic perspectives and recent advances in major animal models of hypertension. Acta Pharmacol Sin 26: 295-301.
31. Takahashi K, Ouyang X, Komatsu K, Nakamura N, Hattori M, Baba A, Azuma J (2002) Sodium tanshinone IIA sulfonate derived from Danshen (Salvia miltiorrhiza) attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac cells, Biochem Pharmacol 64: 745-749.
32. Takimoto E, Kass DA (2007) Role of oxidative stress in cardiac hypertrophy and remodeling, Hypertension 49: 241-248. (Pubitemid 46142995)
33. Tang F,Wu X,Wang T,Wang P, Li R, Zhang H, Gao J, Chen S, Bao L, Huang H, Liu P (2007) Tanshinone IIAattenuates atherosclerotic calcification in rat model by inhibition of oxidative stress,Vascul Pharmacol 46: 427-438. (Pubitemid 46552282)
34. Wang M, Zhang J, Walker SJ, Dworakowski R, Lakatta EG, Shah AM (2010) Involvement of NADPH oxidase in age-associated cardiac remodeling, J Mol Cell Cardiol 48: 765-772.
35. Weber KT (1997) Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. Circulation 96: 4065-4082.
36. Zhang H, Pi R, Li R,Wang P, Tang F, Zhou S, Gao J, Jiang J, Chen S, Liu P (2007) PPARbeta/delta activation inhibits angiotensin II-induced collagen type I expression in rat cardiac fibroblasts, Arch Biochem Biophys 460: 25-32. (Pubitemid 46482426)
37. Zhou G, Jiang W, Zhao Y, Ma G, Xin W, Yin J, Zhao B (2003) Sodium tanshinone IIA sulfonate mediates electron transfer reaction in rat heart mitochondria, Biochem Pharmacol 65: 51-57. (Pubitemid 35447838)
38. Zhou SG, Zhou SF, Huang HQ, Chen JW, Huang M, Liu PQ (2006) Proteomic analysis of hypertrophied myocardial protein patterns in renovascularly hypertensive and spontaneously hypertensive rats, J Proteome Res 5: 2901-2908. (Pubitemid 44749208)